bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
bluebird bio reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
bluebird bio reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, seven executives at bluebird bio received on average a compensation package of $4.6M, a 26% increase compared to previous year.
Andrew Obenshain, Chief Executive Officer, received $9.3M in total. 59% of Obenshain's compensation, or $5.4M, was in option awards. Obenshain also received $345K in non-equity incentive plan, $486K in salary, $3M in stock awards, as well as $12K in other compensation.
Nick Leschly, Chief Executive Officer, received a compensation package of $7.3M, which increased by 17% compared to previous year. 66% of the compensation package, or $4.8M, was in stock awards.
Jason F. Cole, Chief Business Officer, earned $3.5M in 2021.
Gina Consylman, Chief Financial Officer, received $3.4M in 2021.
William D. Baird, III, Chief Financial Officer, earned $3.1M in 2021, a 30% increase compared to previous year.
Philip D. Gregory, Chief Scientific Officer, received $3.1M in 2021, which increases by 34% compared to 2020.
Thomas J. Klima, Chief Commercial Officer, earned $2.3M in 2021.
Related executives
Andrew Obenshain
bluebird bio
Chief Executive Officer
Gina Consylman
bluebird bio
Chief Financial Officer
Jason Cole
bluebird bio
Chief Strategy & Financial Officer former
Thomas Klima
bluebird bio
Chief Commercial and Operating Officer
Nick Leschly
bluebird bio
Chief Executive Officer
William Baird
bluebird bio
Chief Financial Officer
Philip Gregory
bluebird bio